✦ LIBER ✦

Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist

✍ Scribed by Thomas P. Blackburn; Barry Cox; Craig W. Thornber; Robert J. Pearce

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro studies with ICI 169,369, a che

✍ Thomas P. Blackburn; Craig W. Thornber; Robert J. Pearce; Barry Cox 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 687 KB

In vivo pharmacology of irindalone, a 5-

✍ Jørn Arnt; Klaus P. Bøgesø; Vita Boeck; Anne V. Christensen; Nils Dragsted; John 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

Interaction of the novel antipsychotic a

✍ Arlene D. Stark; Shaun Jordan; Kelly A. Allers; Robert L. Bertekap; Ruoyan Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 276 KB

Differential influence of selective 5-HT

✍ Robert L. Gannon; Jean-Louis Peglion; Mark J. Millan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 738 KB

Pharmacological studies on YM992, a nove

✍ Hiromi Takeuchi; Shin-ichi Yatsugi; Ken-ichi Hatanaka; Kazuhiro Nakato; Hanae Ha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 553 KB

Pharmacological characterization of MP34

✍ Anna Wesołowska; Maria H. Paluchowska; Krystyna Gołembiowska; Ewa Chojnacka-Wójc 📂 Article 📅 2003 🏛 Pharmaceutical Press 🌐 English ⚖ 296 KB